Permission granted to appeal High Court judgment on consent for puberty-blocking treatment

19 January 2021

On 1 December 2020 the High Court ruled that children and young people may not be able to consent to puberty-blocking treatment in cases of gender dysphoria.

The Tavistock and Portman NHS Trust, which leads the national Gender Identity and Development Service (GIDS), has today (Monday 18 January) been granted permission by the court to appeal against the ruling, alongside University College Hospitals NHS Foundation Trust and Leeds Teaching Hospitals NHS Trust, whose paediatric endocrinologists prescribe and administer puberty-blocking drugs on behalf of GIDS. 

On 1 December 2020 the High Court ruled that children and young people may not be able to consent to puberty-blocking treatment in cases of gender dysphoria.

The Tavistock and Portman NHS Trust, which leads the national Gender Identity and Development Service (GIDS), has today (Monday 18 January) been granted permission by the court to appeal against the ruling, alongside University College Hospitals NHS Foundation Trust and Leeds Teaching Hospitals NHS Trust, whose paediatric endocrinologists prescribe and administer puberty-blocking drugs on behalf of GIDS. 

Our statement in response to the court’s decision today is as follows:

A spokesperson for the Trust said: “We welcome the court’s decision to allow us to appeal against the ruling. Our priority is to work together with our partners to support our patients and their families while legal proceedings are ongoing.”

For accurate and up-to-date information about the ruling and the appeal visit the GIDS website: https://gids.nhs.uk.

Journalists should email communications@tavi-port.nhs.uk 

Share this page

Gender identity development service (GIDS)

For children and young people, and their families, who experience difficulties in the development of their gender identity.